These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 1447173

  • 1. Hirudisins. Hirudin-derived thrombin inhibitors with disintegrin activity.
    Knapp A, Degenhardt T, Dodt J.
    J Biol Chem; 1992 Dec 05; 267(34):24230-4. PubMed ID: 1447173
    [Abstract] [Full Text] [Related]

  • 2. Chimeric antithrombin peptide. Characterization of an Arg-Gly-Asp (RGD)- and hirudin carboxyl terminus-containing synthetic peptides.
    Church FC, Phillips JE, Woods JL.
    J Biol Chem; 1991 Jun 25; 266(18):11975-9. PubMed ID: 2050691
    [Abstract] [Full Text] [Related]

  • 3. Triflavin, an Arg-Gly-Asp containing snake venom peptide, inhibits aggregation of human platelets induced by human hepatoma cell line.
    Sheu JR, Lin CH, Chung JL, Teng CM, Huang TF.
    Thromb Res; 1992 Jun 15; 66(6):679-91. PubMed ID: 1519227
    [Abstract] [Full Text] [Related]

  • 4. The Arg-Gly-Asp-containing peptide, rhodostomin, inhibits in vitro cell adhesion to extracellular matrices and platelet aggregation caused by saos-2 human osteosarcoma cells.
    Chiang HS, Yang RS, Huang TF.
    Br J Cancer; 1995 Feb 15; 71(2):265-70. PubMed ID: 7841039
    [Abstract] [Full Text] [Related]

  • 5. Insertion of the Asp-Ser/Phe sequence in the P' position of hirutonin provides molecules having both antithrombin and disintegrin activity.
    Leblond L, DiMaio J, Winocour PD.
    Thromb Res; 1999 Feb 15; 93(4):171-81. PubMed ID: 10064272
    [Abstract] [Full Text] [Related]

  • 6. A novel hirudin derivative characterized with anti-platelet aggregations and thrombin inhibition.
    Mo W, Zhang YL, Chen HS, Wang LS, Song HY.
    J Thromb Thrombolysis; 2009 Aug 15; 28(2):230-7. PubMed ID: 18998199
    [Abstract] [Full Text] [Related]

  • 7. Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb-IIIa.
    Scarborough RM, Naughton MA, Teng W, Rose JW, Phillips DR, Nannizzi L, Arfsten A, Campbell AM, Charo IF.
    J Biol Chem; 1993 Jan 15; 268(2):1066-73. PubMed ID: 8419315
    [Abstract] [Full Text] [Related]

  • 8. The antithrombotic effect of a novel hirudin derivative after reconstruction of carotid artery in rabbits.
    Lu WF, Mo W, Liu Z, Fu WG, Guo DQ, Wang YQ, Song HY.
    Thromb Res; 2010 Oct 15; 126(4):e339-43. PubMed ID: 20483158
    [Abstract] [Full Text] [Related]

  • 9. KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reaction.
    Mazoyer E, Lévy-Toledano S, Rendu F, Hermant L, Lu H, Fiat AM, Jollès P, Caen J.
    Eur J Biochem; 1990 Nov 26; 194(1):43-9. PubMed ID: 2174781
    [Abstract] [Full Text] [Related]

  • 10. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist.
    Huang TF, Liu CZ, Ouyang CH, Teng CM.
    Biochem Pharmacol; 1991 Aug 22; 42(6):1209-19. PubMed ID: 1888330
    [Abstract] [Full Text] [Related]

  • 11. Effect of the hirudin carboxy-terminal peptide 54-65 on the interaction of thrombin with platelets.
    Jandrot-Perrus M, Huisse MG, Krstenansky JL, Bezeaud A, Guillin MC.
    Thromb Haemost; 1991 Sep 02; 66(3):300-5. PubMed ID: 1746000
    [Abstract] [Full Text] [Related]

  • 12. Incorporation of an Asp-Ser sequence to form an RGDS-like motif in hirutonin: the effect on in vitro platelet function.
    van Wyk V, Leblond L, Winocour PD, Devine DV, Gyongyossy-Issa MI.
    Thromb Res; 2000 Aug 15; 99(4):343-52. PubMed ID: 10963785
    [Abstract] [Full Text] [Related]

  • 13. Antithrombin effects of native and recombinant hirudins.
    Markwardt F, Stürzebecher J, Glusa E.
    Biomed Biochim Acta; 1990 Aug 15; 49(5):399-404. PubMed ID: 2271010
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of coagulation and thrombin-induced platelet activities by a synthetic dodecapeptide modeled on the carboxy-terminus of hirudin.
    Jakubowski JA, Maraganore JM.
    Blood; 1990 Jan 15; 75(2):399-406. PubMed ID: 2294999
    [Abstract] [Full Text] [Related]

  • 15. The peptide Glu-His-Ile-Pro-Ala binds fibrinogen and inhibits platelet aggregation and adhesion to fibrinogen and vitronectin.
    Gartner TK, Taylor DB.
    Proc Soc Exp Biol Med; 1991 Oct 15; 198(1):649-55. PubMed ID: 1716370
    [Abstract] [Full Text] [Related]

  • 16. Efficient targeted anticoagulant with active RGD motif.
    Bi Q, Zhou X, Cen X, Qu H, Luo J, Huang Y, Zhu S.
    Thromb Res; 2007 Oct 15; 120(4):541-7. PubMed ID: 17222892
    [Abstract] [Full Text] [Related]

  • 17. Mechanism of action of the antiplatelet peptide, arietin, from Bitis arietans venom.
    Huang TF, Wang WJ, Teng CM, Ouyang C.
    Biochim Biophys Acta; 1991 May 24; 1074(1):144-50. PubMed ID: 2043664
    [Abstract] [Full Text] [Related]

  • 18. Beta 3 integrin derived peptide 217-230 inhibits fibrinogen binding and platelet aggregation: significance of RGD sequences and fibrinogen A alpha-chain.
    Lasz EC, McLane MA, Trybulec M, Kowalska MA, Khan S, Budzynski AZ, Niewiarowski S.
    Biochem Biophys Res Commun; 1993 Jan 15; 190(1):118-24. PubMed ID: 8422238
    [Abstract] [Full Text] [Related]

  • 19. Disagregin is a fibrinogen receptor antagonist lacking the Arg-Gly-Asp sequence from the tick, Ornithodoros moubata.
    Karczewski J, Endris R, Connolly TM.
    J Biol Chem; 1994 Mar 04; 269(9):6702-8. PubMed ID: 8120028
    [Abstract] [Full Text] [Related]

  • 20. Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex.
    Huang TF, Holt JC, Lukasiewicz H, Niewiarowski S.
    J Biol Chem; 1987 Nov 25; 262(33):16157-63. PubMed ID: 3680247
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.